HHealthcare Read More Vertex kidney drug povetacicept succeeds in trial for IgANMarch 10, 2026 A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston. Brian Snyder | Reuters…
HHealthcare Read More These 4 charts show the scale of Novo Nordisk’s woesFebruary 25, 2026 Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…
HHealthcare Read More The big market rotation may lead to gains in this health care name. Trading it with optionsFebruary 24, 2026 While the stock market rarely offers absolute certainties, historical seasonality is a rhythm that plays out more often…
HHealthcare Read More Gilead to buy cancer therapy developer Arcellx for up to $7.8 billionFebruary 23, 2026 A Gilead Sciences office is shown in Foster City, California, U.S. May 1, 2018. Stephen Lam | Reuters…
MMarkets Read More What’s likely to move the market in the next trading sessionAugust 14, 2025 Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and…
MMarkets Read More In unusual occurrence, both the Dow and small caps could be headed for a breakout, charts suggestAugust 13, 2025 As we know, large-cap growth and technology have been breaking out from various bullish patterns over the last…